Daniel-Adriano Silva
Keine laufenden Positionen mehr
Karriereverlauf von Daniel-Adriano Silva
Ehemalige bekannte Positionen von Daniel-Adriano Silva
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROGENE INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2003 | 01.03.2021 |
| Gründer | 01.12.2003 | 01.03.2021 |
Ausbildung von Daniel-Adriano Silva
| Universidad Nacional Autónoma de México | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| Mexiko | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Daniel-Adriano Silva
- Erfahrung
